Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lupin Ltd

NSE: LUPIN · BSE: 500257 · Pharmaceuticals & Biotechnology · 57 announcements

Lupin Ltd news stories on ALFA NewsRead the news →
Share price
₹2,012.90
Market cap
₹92,048 Cr
Revenue (annual)
₹27,958 Cr
Net profit (annual)
₹5,333 Cr
P/E (TTM)
16.6×Sector 47.4×
Promoter holding
46.85%-0.01% QoQ
FII holding
22.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

07:13 IST BSE
Merger & Restructuring

Lupin Merger & Restructuring Worth ₹15.36 Cr

Lupin Inc. licensed two oncology programs to Kaveri Therapeutics in exchange for an 82.2% stake, valued at ₹15.36 Crore.

Value
₹15.36 Cr